AlzeCure delivers positive NeuroRestore candidate results
The therapy reaches and activates areas of the brain that are central to cognitive enhancement
Read More
Tag: NeuroRestore
AlzeCure reveals positive NeuroRestore ACD856 data
Therapy is a positive modulator and has demonstrated that it can improve learning and memory
Read More
AlzeCure demonstrates disease-modifying effects of NeuroRestore ACD856
Data from the study shows that ACD856 has a potential neuroprotective effect in a cellular mode
Read More
- Alzecure shares new preclinical data on NeuroRestore ACD856 at AD/PD conference
- Samsung Bioepis signs partnership with Sandoz for next‑generation biosimilars
- Atrogi begins dosing first subjects in human trial of ATR-258
- R1 Therapeutics launches with $77.5m to advance hyperphosphatemia treatment
- Taiwan Bio partners with Terumo to advance automated Treg manufacturing
